1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Azopt 1% Ophthalmic Suspension: new trials by email Literature Review of Azopt 1% Ophthalmic Suspension trials Research Report on Azopt 1% Ophthalmic Suspension
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes Brinzolamide 1% ophthalmic suspension, Azopt 1% Ophthalmic Suspension - Glaucoma, Open-Angle, Ocular Hypertension | Phase 3 | Completed | Padagis LLC | 495 | 2019-06-24 | 2023-03-06 |
Glaucoma, Open-Angle (1) · Ocular Hypertension (1)
Padagis LLC (1)
United States (1)